Vensana Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Executive Officer, Director)in
BoardLee Cooper(Director)Scott Barclay(Director)Louis Samson(Director)
Board seatPeter Justin Klein· per SEC Form D · $106.3M raise · filed Dec 2024
Co-investorsBattery VenturesBreyer CapitalInsight PartnersLRVHealthNew Leaf Venture Partners
IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.
Deep TechHealthtechMedical DevicesRoseville, US
Todd Kerkow(Co-Founder, President and CEO)inMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)
Board seatAmrinder SinghKirk Nielsen· per SEC Form D
Co-investorsTreo Ventures, LlcHatteras Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.